I am not quite sure how to respond to 'I don't believe' response. Even FDA is approving these mutation targeting drugs without mutation status. Niraparib was a

I am not quite sure how to respond to 'I don't believe' response. Even FDA is approving these mutation targeting drugs without mutation status. Niraparib was approved for Ovarian Cancer even if you don't have HRD mutations. Approval was based on NOVA trial, you can lookup the details. I am not saying there isn't any connection, what I am saying is it not really well understood or clearcut as mutation x = drug y that general public believes about these drugs.